|
| ARG-PRO-PRO-GLY-PHE-SER-PRO-PHE Basic information |
Product Name: | ARG-PRO-PRO-GLY-PHE-SER-PRO-PHE | Synonyms: | RPPGFSPF;(DES-ARG9)-BRADYKININ;H-ARG-PRO-PRO-GLY-PHE-SER-PRO-PHE-OH;ARG-PRO-PRO-GLY-PHE-SER-PRO-PHE;BRADYKININ [DES-ARG9];des-arg(9)-bradykini;bradykinin fragment 1-8;[des-arg9]-bradykinin acetate hydrate | CAS: | 15958-92-6 | MF: | C44H61N11O10 | MW: | 904.02 | EINECS: | | Product Categories: | Peptide | Mol File: | 15958-92-6.mol | ![ARG-PRO-PRO-GLY-PHE-SER-PRO-PHE Structure](CAS/GIF/15958-92-6.gif) |
| ARG-PRO-PRO-GLY-PHE-SER-PRO-PHE Chemical Properties |
density | 1.47±0.1 g/cm3(Predicted) | storage temp. | −20°C | solubility | DMF: 15mg/mL; DMSO: 15mg/mL; Ethanol: 10mg/mL; PBS (pH 7.2): 10mg/mL | form | A crystalline solid | pka | 3.56±0.10(Predicted) |
| ARG-PRO-PRO-GLY-PHE-SER-PRO-PHE Usage And Synthesis |
Uses | [Des-Arg9]-Bradykinin was used to study new bradykinin antagonists having very high potency at B1 receptors. | Definition | ChEBI: An eight-membered oligopeptide comprising Arg, Pro, Pro, Gly, Phe, Ser, Pro and Phe residues joined in sequence. It is an analogue of bradykinin lacking the Arg residue at position 9. |
| ARG-PRO-PRO-GLY-PHE-SER-PRO-PHE Preparation Products And Raw materials |
|